Xolair 150 MG/ML 1S

Ended Awarded Last action

Contract number
SPE2DR26FBTVE
Awardee
Awarding agency
Obligated
$18,348

Award facts

Contract value 100% obligated
$18,348.12 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
6515 Medical And Surgical Instruments, Equipment, And Supplies
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 5, 2026, for XOLAIR 150 mg/ml, with a ceiling value of $18,348.12, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply across Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL. The order has a firm fixed price and an ultimate completion date of March 24, 2026.

Quick answers

Who was awarded contract SPE2DR26FBTVE?

SPE2DR26FBTVE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 5, 2026.

How much is contract SPE2DR26FBTVE worth?

The government has obligated $18,348 on SPE2DR26FBTVE.

Is contract SPE2DR26FBTVE an order under another contract?

Yes. SPE2DR26FBTVE is a delivery order under SPE2DR25D9628, an indefinite delivery contract.

Was contract SPE2DR26FBTVE competed?

The extent of competition for SPE2DR26FBTVE was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award